SEGMENT REPORTING (Tables)

9 Months Ended

Sep. 30, 2021

SEGMENT REPORTING

Schedule of business segments

	Cure			Sera Labs			Eliminations			Consolidated
Net Sales	$	386		$	4,654		$	(126	)	$	4,914
Operating Loss	$	(7,019	)	$	(5,689	)	$	-		$	(12,708	)
Assets	$	46,604		$	9,450		$	(14,175	)	$	41,879
Accounts receivable, net	$	22		$	186		$	-		$	208
Inventory, net	$	368		$	592		$	-		$	960

	Cure			Sera Labs		Eliminations		Consolidated
Net Sales	$	741		$	-	$	-	$	741
Operating Loss	$	(14,258	)	$	-	$	-	$	(14,258	)
Assets	$	30,066		$	-	$	-	$	30,066
Accounts receivable, net	$	46		$	-	$	-	$	46
Inventory, net	$	228		$	-	$	-	$	228

Schedule of disaggregation of revenue

	Three Months Ended						Nine months Ended
	September 30, 2021			September 30, 2020			September 30, 2021			September 30, 2020
CureFilm™ sales		21	%		98	%		14	%		75	%
Research & Development services		-			-			1			23
Product sales - CBD		78			-			77			-
Product sales – PPE		-			-			7			-
Other sales less than 10%		1			2			1			2
Total		100	%		100	%		100	%		100	%